SCOTTSDALE, AZ - October 31, 2023 - NeoLight, a leading healthcare technology company in the neonatal care space, today announced the appointment of Jerry Gibson to its Advisory Board. With a career spanning over 40 years, Jerry Gibson has consistently demonstrated his expertise and leadership in medical start-up ventures and technology turnarounds. His recent role as Chairman and CEO of Venclose, culminating in a successful merger with Becton Dickinson (BD) at the end of 2021, showcases his strategic acumen in the healthcare industry.
Mr. Gibson spent 15 years with Siemens Medical Solutions, holding various executive positions, including Division Head of Diagnostic Ultrasound, where he oversaw operations in the United States. He initiated his illustrious business career with Xerox Corporation, and his commitment to advancing healthcare extends to his role as Vice Chairman of the External Advisory Board of the University of California/National Science Foundation Center for Biophotonics Science and Technology.
Currently, Mr. Gibson actively participates on multiple Boards of Directors and business Advisory Boards. He is also engaged in the SW Advisory Board of St. Jude's Children's Hospital and contributes his insights to the Risk Capital Committee of the Flinn Foundation. Mr. Gibson is a graduate of the University of Memphis, where he earned his Bachelor of Business Administration degree.
“We are thrilled to welcome Jerry to our Advisory Board,” said Vivek Kopparthi, NeoLight Co-founder and CEO. “His deep experience in the medical device industry, combined with his proven track record of success, will be invaluable as we continue to grow and expand our mission of improving neonatal care.”
“I am honored to join the NeoLight Advisory Board,” said Mr. Gibson. “NeoLight is a truly innovative company with a strong commitment to making a difference in the lives of newborns and their families. I look forward to working with the management team to help NeoLight achieve its ambitious goals.”
Mr. Gibson’s appointment is the latest in a series of strategic moves by NeoLight to strengthen its leadership team and position the company for continued growth. With its strong leadership team and innovative product offerings, NeoLight is well-positioned to continue its growth trajectory and make a significant impact on the neonatal care market.
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
